You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 21, 2024

Jubilant Generics Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for JUBILANT GENERICS, and what generic and branded alternatives to JUBILANT GENERICS drugs are available?

JUBILANT GENERICS has thirty-eight approved drugs.



Summary for Jubilant Generics
US Patents:0
Tradenames:34
Ingredients:33
NDAs:38

Drugs and US Patents for Jubilant Generics

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Jubilant Generics ITRACONAZOLE itraconazole CAPSULE;ORAL 203445-001 Feb 23, 2017 DISCN No No ⤷  Subscribe ⤷  Subscribe
Jubilant Generics BUPROPION HYDROCHLORIDE bupropion hydrochloride TABLET, EXTENDED RELEASE;ORAL 202775-001 Oct 11, 2013 DISCN No No ⤷  Subscribe ⤷  Subscribe
Jubilant Generics AMLODIPINE AND OLMESARTAN MEDOXOMIL amlodipine besylate; olmesartan medoxomil TABLET;ORAL 207450-003 May 15, 2017 DISCN No No ⤷  Subscribe ⤷  Subscribe
Jubilant Generics CITALOPRAM HYDROBROMIDE citalopram hydrobromide TABLET;ORAL 205407-001 Dec 23, 2015 DISCN No No ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.